Integrated safety of levodopa‐carbidopa intestinal gel from prospective clinical trials

BACKGROUND: Continuous administration of levodopa‐carbidopa intestinal gel (carbidopa‐levodopa enteral suspension) through a percutaneous endoscopic gastrojejunostomy is a treatment option for advanced Parkinson disease (PD) patients with motor fluctuations resistant to standard oral medications. Sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang, Anthony E., Rodriguez, Ramon L., Boyd, James T., Chouinard, Sylvain, Zadikoff, Cindy, Espay, Alberto J., Slevin, John T., Fernandez, Hubert H., Lew, Mark F., Stein, David A., Odin, Per, Fung, Victor S.C., Klostermann, Fabian, Fasano, Alfonso, Draganov, Peter V., Schmulewitz, Nathan, Robieson, Weining Z., Eaton, Susan, Chatamra, Krai, Benesh, Janet A., Dubow, Jordan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064722/
https://www.ncbi.nlm.nih.gov/pubmed/26695437
http://dx.doi.org/10.1002/mds.26485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064722/
https://www.ncbi.nlm.nih.gov/pubmed/26695437
http://dx.doi.org/10.1002/mds.26485

Ejemplares similares